Liver test study for early fatty liver detection
Part of Digestive system clinical trials.
This study looks at a blood test called ELF to see if it can find early signs of fatty liver disease in people who are at higher risk. The goal is to help catch the problem sooner so it can be treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had an ELF blood test at Methodist Dallas Medical Center between November 2021 and December 2023.
- Your medical records are complete and have follow-up information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find a simple way to detect liver fibrosis, a condition where the liver becomes scarred, in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. By identifying fibrosis early, it may help prevent more serious liver problems.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
This study checks if a simple blood test (LIVERFASt) can accurately measure liver fat and scarring compared to MRI. It may help patients avoid more invasive tests in the future.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
This study looks at whether simple blood tests can help diagnose nonalcoholic fatty liver disease and predict its complications. If you have NAFLD, participating may help doctors find less invasive ways to monitor your liver health.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.